Home
Knowledge Hub

Knowledge Hub

Featured content

From Innovation to Adoption: Why New GLP-1 Delivery Routes Require Human Factors and Training from Day One

From Prescription to Persistence: How “Inside-Out” Patient Engagement Is Reshaping Specialty Pharma

Sustainability in Drug Delivery Is a Human Factors Challenge

01

From Innovation to Adoption: Why New GLP-1 Delivery Routes Require Human Factors and Training from Day One

From Innovation to Adoption: Why New GLP-1 Delivery Routes Require Human Factors and Training from Day One

GLP-1 therapies continue to transform the treatment landscape for obesity and type 2 diabetes. As innovation accelerates, so too does the evolution of how these therapies are delivered.

From Prescription to Persistence: How “Inside-Out” Patient Engagement Is Reshaping Specialty Pharma

From Prescription to Persistence: How “Inside-Out” Patient Engagement Is Reshaping Specialty Pharma

Discover how emerging “inside-out” patient engagement models are transforming specialty pharma by reducing drop-off, improving speed to therapy, and enabling proactive, data-driven support.

Sustainability in Drug Delivery Is a Human Factors Challenge

Sustainability in Drug Delivery Is a Human Factors Challenge

As sustainability goals reshape the pharmaceutical industry, much of the conversation has focused on materials, propellants, and emissions. In respiratory drug delivery, the transition to low global warming potential (low-GWP) propellants is a prime example of this shift, with the potential to significantly reduce the environmental impact of pressurized metered-dose inhalers (pMDIs).

Noble’s Sean Glynn Discusses First-Dose Confidence and Adherence in Pharmaceutical Executive Podcast

Noble’s Sean Glynn Discusses First-Dose Confidence and Adherence in Pharmaceutical Executive Podcast

Noble’s Director of Patient Engagement Services, Sean Glynn, recently appeared on a Pharmaceutical Executive podcast to discuss the role of first-dose experiences in patient adherence and persistence for self-injectable therapies.

From Touchpoints to Moments: Noble’s Perspective Coming Out of the PanAgora Pharma CX Summit

From Touchpoints to Moments: Noble’s Perspective Coming Out of the PanAgora Pharma CX Summit

At the PanAgora Pharma CX Summit, one theme stood out across nearly every conversation: customer experience is no longer a supporting function in pharma. It is a core growth lever that directly influences treatment decisions, adherence, trust, and long-term value.

Aptar and Enable Injections Advance Patient‑Centered Digital Support

Aptar and Enable Injections Advance Patient‑Centered Digital Support

As combination products continue to advance, the industry is moving beyond reliable drug delivery alone—and toward solutions that support patients throughout the entire treatment journey.